Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4633s-4636s, September 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de-Thé, G.
Right arrow Articles by Fortune, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de-Thé, G.
Right arrow Articles by Fortune, R.

Comparative Seroepidemiology of HTLV-I and HTLV-III in the French West Indies and Some African Countries1

G. de-Thé, A. Gessain, L. Gazzolo, M. Robert-Guroff, G. Najberg, A. Calender, M'Pangi Peti, G. Brubaker, A. Bensliman, F. Fabry, M. Strobel, Y. Robin and R. Fortune

Laboratory of Epidemiology and Immunovirology of Tumors, Faculty of Medicine A. Carrel, 69372 Lyon, Cedex 08, France [G. de-T., A. G., L. G., G. N., A. C.]; Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland [M. R-G., G. N.]; National Institute of Hygiene, Warsaw, Poland [G. N.]; Hopital Compagnie Sucrière, Kwilu Ngongo, Zaire [P. M.]; Shirati Hospital, Private Bag, Musoma, Tanzania [G. B.]; Hopital Militaire Avicenne, Service d'Immunologie, Marrakech, Maroc [A. B.]; Centre Hospitalier Lyon-Sud, Unité d'Hygiène et Epidémiologie, 69360 Pierre-Bénite, France [F. F.]; D. D. A. S. S., 19, rue Schoelcher, 97300 Cayenne [M. S.]; Institut Pasteur de la Guyane Française, 97306 Cayenne Cedex [Y. R.]; and Government Laboratory of Health Service, Island of Dominica [R. F.]

The prevalence of antibodies detected by ELISA against human T-lymphotropic viruses, type I (HTLV-I) and type III (HTLV-III-LAV), is described in a comparative serosurvey in the French West Indies and African countries. The data confirm that the Caribbean basin is endemic for HTLV-I. In this region, HTLV-I antibody prevalence varied from 3.4% to 5.2% among blood donors and increased with age to reach a value of 33% among elderly people from the Dominica Island. In French Guyana, a South American country bordering the Caribbean sea, differences in antibody distribution across three ethnic groups (black Bonis, Indian Wayanas, and Hmongs from Asia) provide clues for investigation of the mode of HTLV-I transmission. Africa appears to be an endemic continent for HTLV-I and HTLV-III. For both viruses, the antibody prevalence exhibited an increasing gradient from northern to equatorial through Sudanic areas. These preliminary data by showing that Africa represents an endemic reservoir of HTLVs and, possibly, of other human retroviruses should stimulate further investigations on the natural history and the geographical origin of these viruses.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.